Company: LCTX
Filing Date: 2025-03-10
Form Type: 10-K
Source: 0000950170-25-036309
Chunk: 217

Company: Lineage Cell Therapeutics, Inc.
Filing Date: 2025-03-10
Form: 10-K
Item: Item 1B
Chunk 217
---
(b)(10) as indicated therein.

ITEM 16. FORM 10-K SUMMARY

None.

139

SIGNATURES 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report on Form 10-K to be signed on its behalf by the undersigned, thereunto duly authorized.

    Date: March 10, 2025
     
    LINEAGE CELL THERAPEUTICS, INC.

    By:
    /s/ Brian M. Culley

    Brian M. Culley

    Chief Executive Officer

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

    Signature
     
    Title
     
    Date

    /s/ Brian M. Culley
     
    Chief Executive Officer and Director
     
    March 10, 2025

    BRIAN M. CULLEY
     
    (Principal Executive Officer)

    /s/ Jill Ann Howe 
     
    Chief Financial Officer 
     
    March 10, 2025

    JILL ANN HOWE
     
    (Principal Financial and Accounting Officer)

    /s/ Deborah Andrews
     
    Director
     
    March 10, 2025

    DEBORAH ANDREWS

    /s/ Dipti Amin
     
    Director
     
    March 10, 2025

    DIPTI AMIN

    /s/ Don M. Bailey
     
    Director
     
    March 10, 2025

    DON M. BAILEY

    /s/ Neal C. Bradsher
     
    Director
     
    March 10, 2025

    NEAL C. BRADSHER

    /s/ Anula Jayasuriya
     
    Director
     
    March 10, 2025

    ANULA JAYASURIYA

    /s/ Michael H. Mulroy
     
    Director
     
    March 10, 2025

    MICHAEL H. MULROY

    /s/ Angus C. Russell
     
    Director
     
    March 10, 2025

    ANGUS C. RUSSELL

140